← BackBrowse analysis archive →
CORRECTED — Impact Biomedical (NYSE: IBO) Announces 1-for-12.62 Reverse Stock Split to Complete Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
GlobeNewsWire · 59d ago · Sentiment -0.15
Read original ↗Impact scope
1 industry
direct 1
Top gainer
🔒
Top loser
🔒
Impact chainNews → industry → company, ranked top-down by impact
Pro only
Impact chains, crowding, market view and insider signals — try Pro free for 7 days when you sign up.
Start my free trial